## Abstract ## Background Endovenous laser ablation (EVLA) is a popular minimally invasive treatment for varicose veins. Surgical treatment, featuring junctional ligation and inversion stripping, has shown excellent clinical and cost effectiveness. The clinical effectiveness of both treatments was
Clinical and technical outcomes from a randomized clinical trial of endovenous laser ablation compared with conventional surgery for great saphenous varicose veins
โ Scribed by D. Carradice; A. I. Mekako; F. A. K. Mazari; N. Samuel; J. Hatfield; I. C. Chetter
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 121 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.7615
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Background
This report describes the clinical effectiveness and recurrence rates from a randomized trial of endovenous laser ablation (EVLA) and surgery for varicose veins.
Methods
Some 280 patients were randomized equally using sealed opaque envelopes to two parallel groups: surgery and EVLA. Inclusion criteria included symptomatic disease secondary to primary, unilateral, isolated saphenofemoral junction incompetence, leading to reflux into the great saphenous vein (GSV). Outcomes were: technical success, recurrent varicose veins on clinical examination, patterns of reflux on duplex ultrasound examination, and the effect of recurrence on quality of life, assessed by the Aberdeen Varicose Vein Questionnaire (AVVQ). Assessments were at 1, 6, 12 and 52 weeks after the procedure.
Results
Initial technical success was greater following EVLA: 99ยท3 versus 92ยท4 per cent (P = 0ยท005). Surgical failures related mainly to an inability to strip the above-knee GSV. The clinical recurrence rate at 1 year was lower after EVLA: 4ยท0 versus 20ยท4 per cent (P < 0ยท001). The number of patients needed to treat with EVLA rather than surgery to avoid one recurrence at 1 year was 6ยท3 (95 per cent confidence interval 4ยท0 to 12ยท5). Twelve of 23 surgical recurrences were related to an incompetent below-knee GSV and ten to neovascularization. Of five recurrences after EVLA, two were related to neoreflux in the groin tributaries and one to recanalization. Clinical recurrence was associated with worse AVVQ scores (P < 0ยท001).
Conclusion
EVLA treatment had lower rates of clinical recurrence than conventional surgery in the short term. Registration number: NCT00759434 (http://www.clinicaltrials.gov).
๐ SIMILAR VOLUMES
## Abstract ## Background Endovenous laser ablation (EVLA) is a minimally invasive technique for treating varicose veins due to truncal vein incompetence. This randomized trial compared EVLA with conventional surgery in patients with primary saphenofemoral and great saphenous vein (GSV) reflux. #
## Abstract ## Background This randomized trial compared four treatments for varicose great saphenous veins (GSVs). ## Methods Five hundred consecutive patients (580 legs) with GSV reflux were randomized to endovenous laser ablation (980 and 1470 nm, bare fibre), radiofrequency ablation, ultraso
Background: This was the long-term follow-up of a previously reported randomized clinical trial comparing endovenous laser ablation (EVLA) with cryostripping for great saphenous varicose veins. Methods: A total of 120 patients with great saphenous varicose veins were randomized 1 : 1 to EVLA or cry